Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott Okuno

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
Cancer|April 4, 2003
Phase II trial of gemcitabine in patients with advanced sarcomas (E1797): a trial of the Eastern Cooperative Oncology GroupScott Okuno, Louise M Ryan, John H Edmonson, et al.
Journal of Oncology|January 25, 2022
Pazopanib in Patients with Osteosarcoma Metastatic to the Lung: Phase 2 Study Results and the Lessons for Tumor MeasurementPaul Frankel, Chris Ruel, An Uche, et al.
Journal of Palliative Medicine|February 16, 2024
Improve Advance Care Planning: A Brief Report Discussing Goals of Care Interventions to Improve Communication Among Health Care Teams and Patients Maximizing the Use of the Electronic Health Record ToolsPatty Horecki, James Deming, Meg Lagunas, et al.
Cancer|September 12, 2019
Results of a prospective phase 2 study of pazopanib in patients with surgically unresectable or metastatic chondrosarcomaWarren Chow, Paul Frankel, Chris Ruel, et al.
Cancer|February 3, 2011
A phase 2 study of temsirolimus (CCI-779) in patients with soft tissue sarcomas: a study of the Mayo phase 2 consortium (P2C)Scott Okuno, Howard Bailey, Michelle R Mahoney, et al.
American Journal of Clinical Oncology|February 4, 2014
Chemotherapy, Irradiation, and Surgery for Function-preserving Curative Therapy of Primary Extremity Soft Tissue Sarcomas: Initial Treatment With I-MAP and Inhalation GM-CSF During Preoperative Irradiation and PostoperativelyScott Okuno, Ivy Petersen, Thomas Shives, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 30, 2005
Evaluation of epothilone B analog in advanced soft tissue sarcoma: a phase II study of the phase II consortiumScott Okuno, William J Maples, Michelle R Mahoney, et al.
Sarcoma|November 27, 2018
SARC018_SPORE02: Phase II Study of Mocetinostat Administered with Gemcitabine for Patients with Metastatic Leiomyosarcoma with Progression or Relapse following Prior Treatment with Gemcitabine-Containing TherapyEdwin Choy, Karla Ballman, James Chen, et al.
Sarcoma|September 20, 2019
Corrigendum to "SARC018_SPORE02: Phase II Study of Mocetinostat Administered with Gemcitabine for Patients with Metastatic Leiomyosarcoma with Progression or Relapse following Prior Treatment with Gemcitabine-Containing Therapy"Edwin Choy, Karla Ballman, James Chen, et al.
The Journal of Bone and Joint Surgery. American Volume|March 4, 2009
Effect of time to resumption of chemotherapy after definitive surgery on prognosis for non-metastatic osteosarcomaHamayun Imran, Felicity Enders, Mark Krailo, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Cancer|April 4, 2003
Phase II trial of gemcitabine in patients with advanced sarcomas (E1797): a trial of the Eastern Cooperative Oncology GroupScott Okuno, Louise M Ryan, John H Edmonson, et al.
Journal of Oncology|January 25, 2022
Pazopanib in Patients with Osteosarcoma Metastatic to the Lung: Phase 2 Study Results and the Lessons for Tumor MeasurementPaul Frankel, Chris Ruel, An Uche, et al.
Journal of Palliative Medicine|February 16, 2024
Improve Advance Care Planning: A Brief Report Discussing Goals of Care Interventions to Improve Communication Among Health Care Teams and Patients Maximizing the Use of the Electronic Health Record ToolsPatty Horecki, James Deming, Meg Lagunas, et al.
Cancer|September 12, 2019
Results of a prospective phase 2 study of pazopanib in patients with surgically unresectable or metastatic chondrosarcomaWarren Chow, Paul Frankel, Chris Ruel, et al.
Cancer|February 3, 2011
A phase 2 study of temsirolimus (CCI-779) in patients with soft tissue sarcomas: a study of the Mayo phase 2 consortium (P2C)Scott Okuno, Howard Bailey, Michelle R Mahoney, et al.
American Journal of Clinical Oncology|February 4, 2014
Chemotherapy, Irradiation, and Surgery for Function-preserving Curative Therapy of Primary Extremity Soft Tissue Sarcomas: Initial Treatment With I-MAP and Inhalation GM-CSF During Preoperative Irradiation and PostoperativelyScott Okuno, Ivy Petersen, Thomas Shives, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 30, 2005
Evaluation of epothilone B analog in advanced soft tissue sarcoma: a phase II study of the phase II consortiumScott Okuno, William J Maples, Michelle R Mahoney, et al.
Sarcoma|November 27, 2018
SARC018_SPORE02: Phase II Study of Mocetinostat Administered with Gemcitabine for Patients with Metastatic Leiomyosarcoma with Progression or Relapse following Prior Treatment with Gemcitabine-Containing TherapyEdwin Choy, Karla Ballman, James Chen, et al.
Sarcoma|September 20, 2019
Corrigendum to "SARC018_SPORE02: Phase II Study of Mocetinostat Administered with Gemcitabine for Patients with Metastatic Leiomyosarcoma with Progression or Relapse following Prior Treatment with Gemcitabine-Containing Therapy"Edwin Choy, Karla Ballman, James Chen, et al.
The Journal of Bone and Joint Surgery. American Volume|March 4, 2009
Effect of time to resumption of chemotherapy after definitive surgery on prognosis for non-metastatic osteosarcomaHamayun Imran, Felicity Enders, Mark Krailo, et al.
Pageof 4